The second futility analysis in the PLIANT study completed

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
The second futility analysis in the PLIANT study completed and approved

Stockholm, 2014-09-09 08:00 CEST (GLOBE NEWSWIRE) -- The DSMB reports that the second futility analysis that includes an additional 30 patients has been completed and that no negative impact on the anticancer effect of the chemotherapy drug has been observed.

The analysis covers the first 60 patients in the study who have completed four treatment cycles with the chemotherapy mixture FOLFOX after pretreatment with either PledOx® or placebo. The approval means that PledOx did not weaken the anticancer effect of FOLFOX and that the PLIANT trial can thus proceed with recruitment of patients as planned.

In the PLIANT study the drug PledOx is tested to reduce serious side effects from FOLFOX treatment of colorectal cancer. Many chemotherapy treatments can't be completed as planned due to serious and life-threatening side effects. The primary objective with the PLIANT study is to evaluate the reduction of adverse events related to a decrease in white blood cells (neutrophils) and sensory nerve disorders (neuropathy).

Another futility analysis will be conducted after 90 patients have undergone four treatment cycles with chemotherapy, after pretreatment with either PledOx or placebo.

For further information, please contact:

Jacques Näsström, CEO

+46 737 13 09 79

Jacques.nasstrom@pledpharma.se

Michaela Gertz, CFO

+46 709 26 17 75

Michaela.gertz@pledpharma.se

About PledPharma

PledPharma is a Swedish pharmaceutical company that develops new therapies for the treatment of life threatening diseases. The initial objective is to develop a drug, PledOx®, which reduces severe side-effects associated with chemotherapy. The current market for supportive cancer care is some USD 10 billion. PledPharma also evaluates an existing medicines possibility to reduce the damage that occurs on the heart muscle when patients suffer from acute myocardial infarction. In addition to these projects, the company is also evaluating opportunities of using our technology platform in additional areas where there is a significant unmet medical need. PledPharma has the potential to offer patients valuable and unique treatments for serious life-threatening diseases where there is an opportunity fast registration in the US through "breakthrough therapy" designation. This means that the company has the potential to offer shareholders a good return on their investment. PledPharma (STO:PLED) is listed on NASDAQ OMX First North. Erik Penser Bankaktiebolag is the Certified Adviser. For further information, please visit www.pledpharma.se

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sandals Foundation: Win a Trip, Boost Caribbean Education

Updated Category News Views 6

Sandals Resorts Stakes a Claim in Education While the rest of us are gravitating towards Black Friday deals and Cyber Monday sales, the Sandals Foundation decided to play a different game. This Giving Tuesday, they invite travelers not just to soak in the sun, but to spread a little of it around by supporting education for kids across the Caribbean. It's a classic example...

Continue Reading
Tammy Keller's Devotional Guides Living with Purpose

Updated Category News Views 138

Finding Meaning in the Dash of Life Life isn’t just bookended by birth and death; it’s the dash in between that counts. If you were sitting next to Tammy Keller right now, you’d probably hear that heartfelt truth straight from her. Her new work, "Your--Dash Devotional," rattles the soul by offering a profound look at making every moment intentional, vivid, and...

Continue Reading
Chicago Auto Show: Run & Explore Indoors This February

Updated Category News Views 41

Nobody’s thinking about running laps when they walk into a colossal auto show, but the Chicago Auto Show isn't letting the pedal ease off the gas. Swing by on February 14, folks, for something not typically seen on the floors of McCormick Place. Run participants have got one hour to log as many miles as they can on the 2.4-mile loop right inside the show. Why a Running...

Continue Reading
Galileo's Robot Dog Takes Charge in Polish Warehouses

Updated Category News Views 179

Robotic Innovation Makes Waves in Europe You ever think you’d see the day when a dog—albeit a robotic one—takes the night shift at a warehouse? Well, here we are. Galileo Robotics has unleashed its C1-W robot dog in Poznan, Poland, and it's more than just a fancy tech gimmick. This thing's got potential, bridging gaps left wide open by human labor shortages and...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 61

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
Neil deGrasse Tyson Headlines HIMSS27 with Cosmic Insights

Updated Category News Views 153

celebrated science communicator, is set to close out the HIMSS27 conference with a keynote that's bound to leave a lasting impression. It's a fitting intersection of stars and stethoscopes, as the astrophysicist brings his expansive lens to the nitty-gritty of healthcare innovation. Splicing Science with Storytelling Folks, this ain't your standard healthcare gathering....

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 114

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Sasol AGM Resolutions Passed in One Swift Swing

Updated Category News Views 192

Sasol's AGM Delivers Smooth Sailing for Shareholders Can't say I'm surprised, but Sasol's annual general meeting on the 13th of November went off without a hitch—unless, of course, you're one of those folks who just loves fireworks at these gatherings. The entire set of resolutions danced through with a resounding "Aye," making it one heck of a day for anyone banking on...

Continue Reading
Stellus PBDC's Q3: Solid Income but NAV Drops

Updated Category News Views 56

Stellus PBDC: Q3 Earnings and Strategic Moves Things are getting interesting in Houston where Stellus Private Credit BDC just laid out its financial cards for the third quarter of 2026. Now, I’ve seen my fair share of quarterly reports, but Stellus seems to have stitched a quilt of mixed results this time around. Investment Income and Portfolio Shifts First off, net...

Continue Reading
ZTE Reinvents Energy for AI Data Centers

Updated Category News Views 200

The Great Race: Power and AI in Sync Here we are, neck-deep in the AI era, where the demand for raw computing power just won’t quit. With every data-hungry application and supercharged algorithm, companies are scrambling to keep up. But there’s a nasty little dragon in this fairy tale—energy efficiency. ZTE isn’t just acknowledging this beast; they’re ready to...

Continue Reading

Top 5 Most Recently Viewed Articles

Edward H. McKay Takes Helm as New CEO of Shenandoah Telecommunications

Updated Category News Views 218

Leadership Change at Shenandoah Telecommunications Shenandoah Telecommunications Company, often referred to as "Shentel," has officially announced a significant leadership transition. Edward H. "Ed" McKay has been appointed as the new President and Chief Executive Officer. This change is set to take place on a specified date in the near future, as current President and...

Continue Reading
Projected Growth of Security Printing Market to USD 5.79 Billion

Updated Category News Views 118

Security Printing Market Overview SkyQuest has forecasted that the global security printing market will achieve a remarkable valuation of USD 5.79 billion by the year 2031. This represents a compound annual growth rate (CAGR) of 3.10% during the projection period, which spans from 2024 to 2031. The driving force behind this growth is the collective efforts of governments...

Continue Reading
Prosperity Bancshares, Inc. and Southwest Bancshares Unite

Updated Category News Views 136

Prosperity Bancshares, Inc. Merges with Southwest Bancshares In an exciting development for the banking sector, Prosperity Bancshares, Inc. has officially completed its merger with Southwest Bancshares, Inc. This strategic consolidation promises to bring enhanced customer service and a richer array of financial products, benefiting customers in various ways. As the...

Continue Reading
Revolutionizing AI Security Standards: Wallarm's A2AS Framework

Updated Category News Views 970

Wallarm's Role in Advancing AI Security Today, Wallarm announced its significant contribution to the release of "A2AS: Agentic AI Runtime Security and Self-Defense." This innovative project, spearheaded by Eugene Neelou, aligns various industry leaders, including AWS, Cisco, Google, and more, to fortify the foundation of AI security protocols. The A2AS Framework: A New...

Continue Reading
R2 Wireless Expands Operations with New US Leadership Team

Updated Category News Views 355

R2 Wireless Expands Operations with New Leadership R2 has made a significant stride in addressing the increasing threats and advancements in Electronic Warfare and Counter-UAS programs. The company has launched its US operations and appointed Mr. Cordell Bennigson as its US CEO. Strategic Move for Growth This strategic decision comes in response to the rising global...

Continue Reading